Novartis is reimagining how it collaborates with law firms and legal services providers alike with the bold ambition to redefine shared value in its collaborations while at the same time driving more diversity and inclusion in the legal profession. “We recognize that corporate legal departments have an incredibly important role to play in ensuring that the legal profession accelerates its efforts to make meaningful progress when it comes to diversity and inclusion,” said Shannon Thyme Klinger, Group General Counsel of Novartis. “Building on our company’s public pledge to achieve pay …
- FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)1
- Substantial unmet need exists among patients with METex14 mutated advanced NSCLC as there are no treatment options approved to specifically target this aggressive form of lung cancer
- Capmatinib review expected to be completed within six months
Basel, February 11, 2020 — Novartis announced …
Statement
Feb 05, 2020
We are aware of the recent Ministry of Health (MoH) announcement, that five EU states (Belgium, the Netherlands, Luxembourg, Austria and Ireland) have issued a joint statement regarding our Global Managed Access Program (MAP).
In December, we announced a global MAP to make AVXS-101 available to eligible patients in countries where it is not approved by regulatory authorities. We collaborated with an independent bioethics advisory committee, including a range of experts including clinicians, bioethicists, patient …
World Cancer Day is an international day marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment. Cancer is the leading cause of disease-related death among working-age adults in high-income and middle-income countries.
This World Cancer Day, we’re shining a light on our commitment to our employees impacted by cancer. We are reimagining cancer in the workplace through the global program ‘Ensemble – Caring for colleagues’ with oncology experts and human resources personel, who serve as internal volunteers.
…
“You have cancer.”
These three words have the power to alter the course of one’s life – whether they’re receiving the news, or divulging the information to a loved one. A cancer diagnosis can be difficult to process, and for many, the diagnosis and corresponding treatment plan will not be the sole consideration.
Cancer affects, and claims the lives of, people at a younger age than any other highly prevalent chronic disease – often while they are in the midst of their careers, supporting their families, raising children, and building toward their dreams and aspirations in life. …
- Successful acquisition of Aspen’s Japanese operations and assets reinforces strategic focus on Japan, world’s third largest market for generics and off-patent medicines
- Acquired portfolio complements existing Sandoz portfolio and consists primarily of off-patent branded medicines with focus on anaesthetics and specialty brands
- Transaction enables Sandoz to increase portfolio and pipeline offerings in hospital setting, expanding number of patients who can gain access to these important medicines
Holzkirchen, …
- New Cosentyx® (secukinumab) US label to include 300 mg up-titration option is based on Phase III MEASURE 3 study results in ankylosing spondylitis (AS)1
- Label update provides clinicians with greater choice for their patients, based on clinical response to treatment
- Novartis has submitted to FDA and EMA for approval in non-radiographic axial spondyloarthritis (nr-axSpA)2,3; potentially providing patients with a treatment that addresses the axSpA disease spectrum
…
- Successful acquisition of Aspen’s Japanese operations and assets reinforces strategic focus on Japan, world’s third largest market for generics and off-patent medicines
- Acquired portfolio complements existing Sandoz portfolio and consists primarily of off-patent branded medicines with focus on anaesthetics and specialty brands
- Transaction enables Sandoz to increase portfolio and pipeline offerings in hospital setting, expanding number of patients who can gain access to these important medicines
Holzkirchen, …
- Sandoz officially recognized by Top Employers Institute for its exceptional employee offerings globally
- People-first policies such as global equal parental leave for 14 weeks and joining the Equal Pay International Coalition contributed to recognition
- Second such annual certification for Sandoz, underlining ongoing commitment to attract and keep best talent by building a great place to work
Holzkirchen, January 30, 2020 – Sandoz, a Novartis division, is pleased to announce that it has been officially awarded the “Global Top Employer 2020” …
- Sandoz officially recognized by Top Employers Institute for its exceptional employee offerings globally
- People-first policies such as global equal parental leave for 14 weeks and joining the Equal Pay International Coalition contributed to recognition
- Second such annual certification for Sandoz, underlining ongoing commitment to attract and keep best talent by building a great place to work
Holzkirchen, January 30, 2020 – Sandoz, a Novartis division, is pleased to announce that it has been officially awarded the “Global Top Employer 2020” …
Follow us on Facebook
ADDRESS – ZIMBABWE
Suite 204, Block 1
Long Cheng Plaza
Mutley Bend, Belvedere
Harare, Zimbabwe
ADDRESS – ZAMBIA
Plot 43504
Apex Chalala
Off Kasama Road
Lusaka Zambia